These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8911690)

  • 1. Loss of Raf-1-binding activity of v-Ha-Ras by the deletion of amino acid residues 64-72 and 143-151.
    Hiwasa T; Kasama M; Nakadai T; Sawada T; Sakiyama S
    Cell Signal; 1996 Aug; 8(5):393-6. PubMed ID: 8911690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of discrete segments of human Raf-1 kinase critical for high affinity binding to Ha-Ras.
    Ghosh S; Bell RM
    J Biol Chem; 1994 Dec; 269(49):30785-8. PubMed ID: 7983008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.
    Stang S; Bottorff D; Stone JC
    Mol Cell Biol; 1997 Jun; 17(6):3047-55. PubMed ID: 9154803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues.
    Chuang E; Barnard D; Hettich L; Zhang XF; Avruch J; Marshall MS
    Mol Cell Biol; 1994 Aug; 14(8):5318-25. PubMed ID: 8035810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation.
    Drugan JK; Khosravi-Far R; White MA; Der CJ; Sung YJ; Hwang YW; Campbell SL
    J Biol Chem; 1996 Jan; 271(1):233-7. PubMed ID: 8550565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors.
    Akasaka K; Tamada M; Wang F; Kariya K; Shima F; Kikuchi A; Yamamoto M; Shirouzu M; Yokoyama S; Kataoka T
    J Biol Chem; 1996 Mar; 271(10):5353-60. PubMed ID: 8621388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras.
    Hu CD; Kariya K; Tamada M; Akasaka K; Shirouzu M; Yokoyama S; Kataoka T
    J Biol Chem; 1995 Dec; 270(51):30274-7. PubMed ID: 8530446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in the mechanism of interaction of Raf-1 and B-Raf with H-Ras.
    Shinkai M; Masuda T; Kariya K; Tamada M; Shirouzu M; Yokoyama S; Kataoka T
    Biochem Biophys Res Commun; 1996 Jun; 223(3):729-34. PubMed ID: 8687465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the interaction of Raf-1 with ras p21 or 14-3-3 protein in intact cells.
    Koyama S; Williams LT; Kikuchi A
    FEBS Lett; 1995 Jul; 368(2):321-5. PubMed ID: 7628630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.
    Hu CD; Kariya Ki; Kotani G; Shirouzu M; Yokoyama S; Kataoka T
    J Biol Chem; 1997 May; 272(18):11702-5. PubMed ID: 9115221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner.
    Spaargaren M; Martin GA; McCormick F; Fernandez-Sarabia MJ; Bischoff JR
    Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):303-7. PubMed ID: 8002932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
    Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
    Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.
    Fridman M; Tikoo A; Varga M; Murphy A; Nur-E-Kamal MS; Maruta H
    J Biol Chem; 1994 Dec; 269(48):30105-8. PubMed ID: 7982912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction.
    Pumiglia K; Chow YH; Fabian J; Morrison D; Decker S; Jove R
    Mol Cell Biol; 1995 Jan; 15(1):398-406. PubMed ID: 7799948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor.
    Herrmann C; Horn G; Spaargaren M; Wittinghofer A
    J Biol Chem; 1996 Mar; 271(12):6794-800. PubMed ID: 8636102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.